hero section gradient
16 handpicked stocks

Next-Gen Proteins

Looking to invest in the future of food? This carefully selected group of stocks represents companies solving our global protein challenges. From plant-based alternatives to agricultural innovation, these stocks have been thoughtfully chosen by our analysts for their potential in this growing market.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Summary of the Next-Gen Proteins basket market capitalisation and investor takeaways based on large-cap dominance.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and closer tracking of broad market performance.
  • Use this basket as a core, long-term portfolio holding rather than a speculative trade.
  • Expect steady, long-term value growth rather than short-term, explosive gains.
Total Market Cap
  • BYND: $1.44B

  • OTLY: $482.24M

  • MOS: $9.26B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection focuses on the entire protein innovation ecosystem. We've identified companies addressing the sustainable food challenge from multiple angles - creating plant-based alternatives, developing lab-grown meat, and improving traditional agriculture with better fertilizers and animal health solutions.

2

What You Need to Know

This investment opportunity spans both established agricultural players and emerging food-tech innovators. The theme aims to capture value across the entire protein production chain, from agricultural inputs to finished food products, positioning investors to benefit from long-term shifts in how we produce protein.

3

Why These Stocks

These companies were selected based on their technological innovation, market position, and growth potential in addressing global food challenges. Our experts identified businesses poised to benefit from increased consumer demand for sustainable protein sources and the regulatory support accelerating this industry.

Why You'll Want to Watch These Stocks

🌱

The Protein Revolution Is Here

Consumer demand for sustainable proteins is skyrocketing, with plant-based alternatives and cellular agriculture gaining mainstream acceptance faster than most analysts predicted.

💰

Big Money Is Betting On Food Tech

Venture capital investment in alternative proteins hit record levels in recent years, with regulators increasingly supporting innovations that address food security and environmental concerns.

🔬

Breakthrough Technologies Emerging

From lab-grown meat to advanced agricultural systems, these companies are developing the technologies that could transform how we feed 10 billion people by 2050.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Streaming Power Dynamics Explained | Content Wars

Streaming Power Dynamics Explained | Content Wars

The resolution of the content dispute between Disney and Google's YouTube TV highlights the critical interdependence of content creators and distributors. This dynamic creates an investment opportunity in companies that are central to the streaming ecosystem, from content production to platform delivery.

Jeep Hybrid Recall Overview: Market Shift Analysis

Jeep Hybrid Recall Overview: Market Shift Analysis

Stellantis is recalling nearly 113,000 Jeep plug-in hybrids because of a serious engine defect, creating potential investment opportunities. This theme focuses on competing automakers and aftermarket parts suppliers that may benefit from a shift in consumer confidence and repair needs.

Frequently Asked Questions